Laster Wr

发表

Development of Human Tumor Xenograft Models for In Vivo Evaluation of New Antitumor Drugs

B. Abbott, J. Mayo, D. Dykes, 1992 .

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

Laster Wr, Schabel Fm, Trader Mw, 1979 .

Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056).

Laster Wr, Schabel Fm, 1975 .

Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.

F. Schabel, T. Corbett, J. Mayo, 1975, Cancer research.

Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives.

H. Skipper, F. Schabel, W. Wilcox, 1963, Cancer chemotherapy reports.

Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.

E. Frei, W. R. Laster, D. Griswold, 1987, Cancer research.

Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.

H. Skipper, F. Schabel, W. R. Laster, 1969, Cancer chemotherapy reports.

Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites.

H. Skipper, F. Schabel, W. Wilcox, 1965, Cancer chemotherapy reports.

Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole.

F. Schabel, R. W. Brockman, W. R. Laster, 1970, Cancer research.